Correlation Between AptaBio Therapeutics and Hyosung Heavy

Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Hyosung Heavy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Hyosung Heavy into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AptaBio Therapeutics and Hyosung Heavy Industries, you can compare the effects of market volatilities on AptaBio Therapeutics and Hyosung Heavy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Hyosung Heavy. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Hyosung Heavy.

Diversification Opportunities for AptaBio Therapeutics and Hyosung Heavy

-0.7

Correlation Coefficient

AptaBio Therapeutics  Hyosung Heavy

Excellent diversification

The 3 months correlation between AptaBio and Hyosung is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Hyosung Heavy Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hyosung Heavy Industries and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Hyosung Heavy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hyosung Heavy Industries has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Hyosung Heavy go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Hyosung Heavy

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to under-perform the Hyosung Heavy. In addition to that, AptaBio Therapeutics is 1.03 times more volatile than Hyosung Heavy Industries. It trades about -0.17 of its total potential returns per unit of risk. Hyosung Heavy Industries is currently generating about 0.17 per unit of volatility. If you would invest  28,400,000  in Hyosung Heavy Industries on August 31, 2024 and sell it today you would earn a total of  11,250,000  from holding Hyosung Heavy Industries or generate 39.61% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.31%
Values	Daily Returns

AptaBio Therapeutics  vs.  Hyosung Heavy Industries

AptaBio Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Hyosung Heavy Industries

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Hyosung Heavy Industries are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Hyosung Heavy sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with AptaBio Therapeutics and Hyosung Heavy

The main advantage of trading using opposite AptaBio Therapeutics and Hyosung Heavy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Hyosung Heavy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hyosung Heavy will offset losses from the drop in Hyosung Heavy's long position.

The idea behind AptaBio Therapeutics and Hyosung Heavy Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.